# FDA Inspection 1171562 - Jubilant Draximage Inc., dba Jubilant Radiopharma - June 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/9eec5bd4-8c1b-4c69-a412-0ff40462ae65
Source feed: FDA_Inspections

> FDA Inspection 1171562 for Jubilant Draximage Inc., dba Jubilant Radiopharma on June 10, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171562
- Company Name: Jubilant Draximage Inc., dba Jubilant Radiopharma
- Inspection Date: 2022-06-10
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1240367 - 2024-04-23](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/54ee0de3-3111-4c44-84a9-488ea6c50f60)
- [FDA Inspection 1035441 - 2017-09-08](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/4abcfcd6-b3e3-4581-bd6d-6f34ab6c5056)
- [FDA Inspection 953137 - 2015-12-17](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/23ad4614-9e19-4ea5-98ac-2bc03b0981ad)
- [FDA Inspection 850564 - 2013-09-17](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/7acce93f-cf78-4659-9616-730f5c9d0935)

Company: https://www.keypedia.com/companies/jubilant-draximage-inc-dba-jubilant-radiopharma/107f9ed8-772f-43cd-98dc-3406bee2f884

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c